NASDAQ: BDSXBiodesix Inc Stock Ownership - Who owns Biodesix?
Insider buying vs selling
Have Biodesix Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Chris Vazquez | Chief Accounting Officer | 2026-02-23 | 211 | $12.78 | $2.70kSell |
| Gary Anthony Pestano | Chief Development Officer | 2026-02-23 | 556 | $12.78 | $7.10kSell |
| Kieran Okane | Chief Commercial Officer | 2026-02-23 | 535 | $12.78 | $6.84kSell |
| Scott Hutton | President CEO | 2026-02-23 | 1,490 | $12.78 | $19.04kSell |
| Robin Harper Cowie | CFO Secy Treasurer | 2026-02-23 | 535 | $12.78 | $6.84kSell |
| Gary Anthony Pestano | Chief Development Officer | 2026-02-10 | 540 | $10.08 | $5.45kSell |
| Scott Hutton | President CEO | 2026-02-10 | 3,559 | $10.08 | $35.89kSell |
| Chris Vazquez | Chief Accounting Officer | 2026-02-10 | 101 | $10.08 | $1.02kSell |
| Robin Harper Cowie | CFO Secy Treasurer | 2026-02-10 | 941 | $10.08 | $9.49kSell |
| Kieran Okane | Chief Commercial Officer | 2026-02-10 | 584 | $10.08 | $5.89kSell |
BDSX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BDSX insiders and whales buy or sell their stock.
BDSX Shareholders
What type of owners hold Biodesix Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Lawrence T. Kennedy Jr. | 298.10% | 30,134,163 | $662.95M | Insider |
| Matthew Strobeck | 53.45% | 5,402,666 | $118.86M | Insider |
| Jack W. Schuler | 25.63% | 2,590,987 | $57.00M | Insider |
| Aigh Capital Management LLC | 7.50% | 758,328 | $16.68M | Institution |
| Telemark Asset Management LLC | 4.85% | 489,824 | $10.78M | Institution |
| Aberdeen Group PLC | 4.54% | 458,438 | $10.09M | Institution |
| Charles M. Watts | 4.17% | 421,705 | $9.28M | Insider |
| Soleus Capital Management LP | 4.12% | 416,599 | $9.17M | Institution |
| John Patience | 3.73% | 377,176 | $8.30M | Insider |
| Hany Massarany | 3.60% | 363,499 | $8.00M | Insider |
BDSX vs Diagnostic & Research Stocks
Biodesix Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.